Janice Mehnert

Dr. Janice Mehnert is a clinical investigator specializing in immunotherapy for rare and difficult-to-treat cancers. She has led innovative basket trials examining checkpoint inhibitors across rare tumor histologies and has been instrumental in characterizing immunotherapy responses in primary peritoneal carcinoma and other rare gynecologic and GI malignancies. Her work has helped establish IO as an option for patients with rare cancers lacking standard therapies.